A Japan clinical oncology group trial for stereotactic body radiation therapy of non-small cell lung cancer

Journal of Thoracic Oncology

Volumn 2, Issue 7 SUPPL.3, 2007, Pages

  Hiraoka, Masahiro ^a   Ishikura, Satoshi ^b  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER   (Japan)

Author keywords

Clinical trial; Stage I non small cell lung cancer; Stereotactic body radiation therapy

Indexed keywords

ADULT; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSIMETRY; HUMAN; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TUMOR VOLUME; WHOLE BODY RADIATION;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; QUALITY CONTROL; RADIATION DOSAGE; RADIOSURGERY;

EID: 34547511229     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318074de1b     Document Type: Conference Paper

References (14)

1. The editorial board of the cancer statistics in Japan. Cancer statistics in Japan 2005. Foundation for promotion of cancer research. Available at http://www.ncc.go.jp/jp/statistics/2005/data03.pdf. Accessed May 24, 2007.
2. Uematsu M, Shioda A, Suda A, et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys 2001;51:666-670.
3. Fukumoto S, Shirato H, Shimzu S, et al. Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomas. Cancer 2002;95:1546-1553.
4. Nagata Y, Negoro Y, Aoki T, et al. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2002;52:1041-1046.
5. Wulf J, Haedinger U, Oppitz U, et al. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 2004;60:186-196.
6. Zimmermann FB, Geinitz H, Schill S, et al. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer 2005;48:107-114.
7. Beitler JJ, Badine EA, El-Sayah, et al. Stereotactic body radiation therapy for nonmetastatic lung cancer: an analysis of 75 patients treated over 5 years. Int J Radiat Oncol Biol Phys 2006;65:100-106.
8. Nyman J, Johansson KA, Hulten U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer-mature results for medically inoperable patients. Lung Cancer 2006;51:97-103.
9. Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004;101:1623-1631.
10. Ishikura S, Teshima T, Ikeda H, et al on behalf of the Japan Clinical Oncology Group. Initial experience of quality assurance in radiotherapy within the Japan Clinical Oncology Group (JCOG). Radiother Oncol 2002;64:S224.
11. Atagi S, Kawahara M, Tamura T, et al. Standard thoracic radiotherapy with or without concurrent daily low-dose carboplatin in elderly patients with locally advanced non-small cell lung cancer: a phase III trial of the Japan Clinical Oncology Group (JCOG9812). Jpn J Clin Oncol 2005;35:195-201.
12. Nishio T, Kunieda E, Shirato H, et al. Dosimetric verification in participating institutions in a stereotactic body radiotherapy trial for stage I non-small cell lung cancer: Japan Clinical Oncology Group trial (JCOG0403). Phys Med Biol 2006;51:5409-5417.
13. McGarry RC, Papiez L, Williams M, et al. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys 2005;63:1010-1015.
14. Timmerman R, McGarry R, Papiez L, et al. Initial report of a prospective phase II trial of stereotactic body radiation therapy for patients with medically inoperable stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2005;63:S99.